Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Details)

v3.23.1
Other current assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Other current assets    
Research and development credits receivable $ 36,363 $ 30,162
Prepayments 6,787 9,472
Clinical materials 1,310 1,279
VAT receivable 355 490
Other current assets 1,664 1,927
Total $ 46,479 $ 43,330